26.04.2024 | Original Article
The efficacy of rhomboid intercostal block for pain management after video-assisted thoracoscopic surgery: a prospective, randomized-controlled trial
verfasst von:
Bahadir Ciftci, Selcuk Alver, Hande Güngör, Birzat Emre Gölboyu, Mahmut Subasi, Burak Omur, Yaşar Gokhan Gul, Mursel Ekinci
Erschienen in:
General Thoracic and Cardiovascular Surgery
Einloggen, um Zugang zu erhalten
Abstract
Objective
We aimed to evaluate the efficacy of rhomboid intercostal block (RIB) for analgesia management in patients who underwent video-assisted thoracoscopic surgery.
Methods
Adult patients who underwent VATS under general anesthesia between July 2020 and June 2022 were included in the study. There was two groups in this study: RIB (n = 25) vs control (n = 25) group. RIB was performed with 30 ml 0.25% bupivacaine at the end of the surgery. Surgical intercostal blockade was performed with 30 ml 0.25% bupivacaine in the control group. The patients received intravenous fentanyl patient-controlled postoperative analgesia. The numerical rating score (NRS), opioid consumption, and adverse events were recorded.
Results
A total of 50 patients were randomized into 2 groups. There were no significant difference in terms of the demographic data between groups (P > 0.05). Postoperative opioid consumption at 0–8, 8–16, 16–24, and 24–48 h and rescue analgesic use were significantly lower in RIB group (P < 0.05). At all times, the static/dynamic NRS were significantly lower in RIB group. The rate of nausea and itching was higher in control group (P < 0.05).
Conclusion
US-guided RIB provides effective post-VATS analgesia.